uniQure N.V. - 54 Year Dividend History | QURE
Historical dividend payout and yield for uniQure N.V. (QURE) since 1971. The current TTM dividend payout for uniQure N.V. (QURE) as of February 21, 2025 is $0.00. The current dividend yield for uniQure N.V. as of February 21, 2025 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.626B |
$0.016B |
|
UNIQURE B.V. is involved in developing gene therapy for patients of genetic or acquired diseases. It offers Glybera for the treatment of lipoprotein lipase deficiency, an orphan metabolic disease. The company's product pipeline includes which are in clinical trials are additional adeno-associated virus consist of AMT-060, AMT-021, AMT-110 and AAV2/glial. UNIQURE B.V. is headquartered in Amsterdam, the Netherlands.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
